Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $3.15B | $3.16B | -0.54% |
Operating Income | $751.4M | $946.7M | -20.63% |
Net Income | $722M | $817.8M | -11.71% |
EPS (Basic) | $6.70 | $7.64 | -12.30% |
EPS (Diluted) | $6.27 | $7.17 | -12.55% |
R&D Expense | $1.25B | $1.1B | +13.37% |
SG&A Expense | $689M | $601.1M | +14.62% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $34.37B | $30.06B | +14.34% |
Current Assets | $18.87B | $16.91B | +11.60% |
Total Liabilities | $7.38B | $6.56B | +12.40% |
Current Liabilities | $3.58B | $3.1B | +15.51% |
Stockholders' Equity | $26.99B | $23.5B | +14.88% |
Cash & Equivalents | $2.6B | $3.92B | -33.56% |
Long-Term Debt | $1.98B | $1.98B | +0.08% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $1.51B | $1.37B | +10.60% |
Investing Cash Flow | $-1.69B | $-235.7M | -615.78% |
Financing Cash Flow | $47.1M | $-322.5M | +114.60% |
Dividends Paid | $0 | — | — |
Share Buybacks | $291.3M | $710.7M | -59.01% |
D&A | $114.1M | $99.5M | +14.67% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 23.9% | 29.9% | -6.05% |
Net Margin | 23.0% | — | — |
ROE | 2.7% | — | — |
ROA | 2.1% | — | — |
Current Ratio | $5.27 | — | — |
Debt to Equity | $0.273 | — | — |
Other companies in Biotechnology